Isolation of proteinaceous α-AMYLASE inhibitor from Bacillus pumilus NGP-1

Authors

  • SHANMUGARAJU VEERAMUTHU Department of Biotechnology, Dr.N.G.P.Arts and Science College, Coimbatore - 48, Tamilnadu, India
  • SURAYYA MOHAMMED Department of Biotechnology, Dr.N.G.P.Arts and Science College, Coimbatore - 48, Tamilnadu, India
  • BIVYA GOPALAN Department of Biotechnology, Dr.N.G.P.Arts and Science College, Coimbatore - 48, Tamilnadu, India

DOI:

https://doi.org/10.22376/ijpbs.2017.8.2.b691-695

Keywords:

Post prandial hyperglycemia, α-amylase inhibitor, Diabetes mellitus, Starch blockers,Porcine pancreatic α-amylase.

Abstract

The present study was conducted to screen the proteinaceous α-amylase inhibitory activity of Bacillus pumilus NGP-1. The culture free supernatant was precipitated by ammonium sulfate at 10-80% saturation for overnight at 4ºC. The precipitated proteins were desalted by dialysis and the protein content was estimated to be 1.3 mg/ml. The α-amylase inhibitory activity of partially purified proteinaceous α-amylase inhibitor was found to be 56%. The proteinaceous α-amylase inhibitor was characterized by Analytical High Performance Liquid Chromatography. The molecular weight of the α-amylase inhibitor was determined by Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis as 29kDa. The results suggested that the proteinaceous α-amylase inhibitor from Bacillus pumilus NGP-1 is first of its kind and may be an important candidate in research of diabetes.

Published

30.06.2017

How to Cite

SHANMUGARAJU VEERAMUTHU, SURAYYA MOHAMMED, & BIVYA GOPALAN. (2017). Isolation of proteinaceous α-AMYLASE inhibitor from Bacillus pumilus NGP-1. International Journal of Pharma and Bio Sciences, 8(2), 691–695. https://doi.org/10.22376/ijpbs.2017.8.2.b691-695

Issue

Section

Research Articles

Categories